Available Forms: Injection
Available Strengths: 500mg
Reference Brands: Monofer (EU/UK)
Category: Anemia
Iron isomaltoside has been shown to be effective in treating iron deficiency anemia across multiple therapeutic patient groups and compared to placebo, IV iron sucrose, and oral iron.
Quick Response Guaranteed | Verified Suppliers
Product Description:
Iron isomaltoside consists of iron and a carbohydrate moiety where the iron is tightly bound in a matrix structure.
Iron(III) Isomaltoside is used to treat iron-deficiency anaemia in patients who cannot tolerate oral iron or require rapid replenishment of iron stores. It helps restore haemoglobin levels and improves symptoms caused by low iron.
It is made from a stable iron–carbohydrate complex containing ferric iron bound to an isomaltoside polymer, which allows controlled and safe release of iron in the body.
The main trade name is Monofer in many international markets.
It is manufactured by Pharmacosmos.
The generic name is Iron(III) Isomaltoside.
The brand name is Monofer.
It is manufactured primarily in Denmark by Pharmacosmos and supplied to global markets.
Strength: 150 mg, 300 mg
Form: Tablets
Reference Brands: Vafseo (EU/EU/UK)
Strength: 5 mg, 20 mg, 50 mg
Reference Brands: Pyrukynd (USA)
Strength: 12.5 mg, 25 mg, 50 mg, and 75 mg
Form: Tablets / Oral suspension
Reference Brands: Promacta (USA), Revolade (EU)
Strength: 1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Form: injection (prefilled syringe)
Reference Brands: EPOGEN (USA), PROCRIT (USA)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under ‘Fair use.’
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.
Online · B2B Pharma · Medical Tourism · NPP